Searchable abstracts of presentations at key conferences in endocrinology

ea0084ps1-05-44 | Miscellaneous | ETA2022

The effect of testosterone supplementation on the hpt axis in euthyroid hypogonadal adult men: a prospective observational study

David Karel , Antonio Leen , Claessens Frank , Vanderschueren Dirk , Decallonne Brigitte

Background and Objective: It is known that androgens decrease and estrogens increase TBG. In female to male transsexuals under testosterone replacement, decrease of TBG has been shown, but also an increased T3/T4 ratio despite stable free T4 and TSH, suggesting increased conversion to T3 by testosterone. We wanted to study the HPT axis in hypogonadal cis-males before and after testosterone replacement.Method: Prospective observational study in adult male...

ea0090p418 | Pituitary and Neuroendocrinology | ECE2023

Search for new biomarkers of adult growth hormone deficiency metabolic syndrome: a comprehensive overview of a four peptides analysis

Mancini Antonio , Vergani Edoardo , Bruno Carmine , Oliva Alessandro , Curro Diego

Adult growth hormone deficiency (aGHD) is characterized by an altered metabolic profile and increased cardiovascular risk. Neudesin is a newly discovered protein mainly secreted from adipose tissue and brain, under evaluation for its possible activity as negative regulator of energy expenditure. Liver expressed antimicrobial peptide (LEAP)-2 is a competitive antagonist of ghrelin on its receptor. Spexin is a polypeptide related to the galanin-kisspeptin family, secreted along ...

ea0090ep585 | Endocrine-related Cancer | ECE2023

Phenotypic presentation of MEN1 (NM_130799.2):c.758delC (p.Ser253CysfsTer28) rs1592648765 pathogenic mutation of MEN-1 gene: a case report

Vergani Edoardo , Concolino Paola , Traini Emanuela , Macis Giuseppe , Mancini Antonio

Multiple endocrine neoplasia (MEN) 1 is a rare hereditary autosomal dominant tumor syndrome characterized by two or more endocrine tumors. Non-endocrine neoplasms have been described as well. MEN1 is caused by inactivating mutations of the onco-suppressor gene MEN-1 (chromosome 11q13) which encodes the protein menin. Currently, 897 public variants of MEN-1 gene are reported. We present the case of a recently discovered pathogenic mutations of MEN-1 gene. A 32-year-old Italian ...

ea0063p451 | Adrenal and Neuroendocrine Tumours 2 | ECE2019

Attributes valued by patients, health-care practitioners (HCPs) and caregivers using pre-filled delivery systems: a systematic literature review

Thanh Xuan-Mai Truong , Rohban Thomas , Ribeiro-Oliveira Jr Antonio

Background: The development of a new syringe for lanreotide Autogel, in conjunction with patients, caregivers and HCPs, identified and integrated several upgrades to the previous design that could improve patient care.Aims: To better understand which attributes are pertinent to users, and how user preferences can be optimally assessed, we conducted a systematic literature review of relevant studies of pre-filled devices.Methods: Pu...

ea0049ep1011 | Pituitary - Clinical | ECE2017

Assessment of macroprolactin through post-PEG monomeric prolactin measurement and comparison with gel fitration chromatography in hyperprolactinemic samples

Ribeiro-Oliveira Antonio , Gontijo Maria do Carmo D

Macroprolactin interference is a common problem in the interpretation of immunoassays for prolactin. Identifying macroprolactinemia can prevent errors in diagnosis and subsequent delivery of treatment to patients. The search for macroprolactin through polyethylene glycol (PEG) precipitation followed by percentage recovery is the most common used method in clinical laboratories. This study aimed to evaluate the implementation of macroprolactin assessment in hyperprolactinemic s...

ea0049ep1390 | Thyroid (non-cancer) | ECE2017

Importance of central compartment neck metastasis in the differentiated thyroid microcarcinomas

Cunha Catia , Guedes Vitor , Garrao Antonio , Cid Olimpia

: Elective central compartment neck dissection in the treatment of differentiated thyroid carcinomas (CDT) remains controversial. In a series of 1500 patients undergoing thyroid surgery, the authors evaluated the prognosis related to central compartment neck metastasis in differentiated microcarcinomas....

ea0041gp204 | Thyroid - Translational & Clinical | ECE2016

Selenium supplementation and autoantibody titers in Graves’ disease

Faltado, Marc Antonio Jr , Yu Gregory , Rosario Acampado Laura

Background: Selenium (Se), a trace mineral with anti-oxidative properties, has been proposed to be potentially beneficial in patients with Graves’ disease (GD), especially those with active Graves’ ophthalmopathy (GO).Methods: Trials evaluating the efficacy of Se among non-pregnant adult GD patients with active GO, versus either placebo or an alternative drug, and on top of standard therapy, were included. A literature search was performed by t...

ea0037gp.14.07 | Diabetes and obesity – Clinical diabetes | ECE2015

Degree of control of type 2 diabetes in Spain according to individualised glycaemic targets

Minambres Inka , Mediavilla Jose Javier , Gonzalez-Segura Diego , Perez Antonio

Our objective was to estimate the distribution of Spanish diabetic patients attending to individualized glycaemic targets recommended by the ADA/EASD consensus with and without considering hypoglycaemia risk. We conducted a cross-sectional study in a Spanish primary care setting between 2011 and 2012. A total of 5382 type 2 diabetic subjects under antihyperglycaemic treatment for at least 3 months prior to inclusion completed a study visit in which clinical data including age,...

ea0037ep173 | Reproduction, endocrine disruptors and signalling | ECE2015

Persistent Mullerian duct syndrome: a case report

Almeida Raquel , Canha Antonio , Santos Jorge , Rocha Anabela , Dores Jorge

Persistent Mullerian duct syndrome (PMDS) is a rare disorder of sex development characterized by the persistence of Mullerian duct derivatives in a genotypic (46,XY) and phenotypic normally virilised male. PMDS is transmitted in an autosomal recessive manner, caused by mutations in the anti-Mullerian hormone gene or in the gene encoding the AMH receptor. The authors report a case of a male patient aged 62 years, with bipolar disorder, referred to the endocrinologist by inciden...

ea0037ep691 | Pituitary: basic and neuroendocrinology | ECE2015

Acute octreotide suppression test in acromegaly: predictive value in long-term response to long-acting somatostatin analogues

Palha Ana , Cortez Luisa , Afonso Antonio , Fonseca Fernando , Agapito Ana

Introduction: The usefulness of acute octreotide suppression test (OST) in the selection of patients with acromegaly for chronic somatostatin analogues (SA) treatment is still controversial.Aim: To investigate the predictive value of OST for long-term responsiveness to long-acting SA.Materials and methods: Retrospective study of 25 drug-naive patients (13 males) with active acromegaly, subjected to an OST (hourly serum GH concentra...